Standards 2007 – Page 26

Information Privacy & Security Policy C-143; End-User nformation Security Policy C-134. Questions regarding your privacy obligations, or reporting of security breaches, should be directed to your local Data Privacy Steward or the Office of Global Privacy at privacyoffice@spcorp.com.

Scientific Integrity

Schering-Plough enters into relationships with doctors, hospitals, universities and contract research organizations to perform clinical trials and other sponsored research. It is critical that we act with objectivity and integrity during these trials and in our relationships with healthcare professionals, veterinarians, collaborators, patients, universities and hospitals.

This means:

Not allowing business pressures or time constraints to compromise the objectivity or integrity of our scientific investigations and the resulting data.
Protecting the safety of research participants comes first.
Following and maintaining good clinical practices ("GCPs") and good laboratory practices ("GLPs") as required by law and regulation.
Communicating objective, complete, honest and accurate information about research programs.
Defining the roles, responsibilities and deliverables for investigators and

(Continued)

...patients, physicians or their family members in call notes. If you have questions about what type of information should be collected in call notes, you should contact your manager, local Data Privacy Steward or local Compliance Officer.

Scientific Integrity

Q. I know a great cardiologist who sees 300 new patients per year and I want him to participate in an upcoming clinical trial. The problem is, the results of the initial study were somewhat negative, and he might not participate if he knows this. Do I even have to mention the results of the initial study?

A. Yes.We have an obligation to give our investigators a clear, complete picture of the study in which they are participating. You should give him all the information, even negative results.